JCR Pharma & Modalis validate initial proof of concept in a joint research programme for development of a novel gene therapy for a CNS disease: Hyogo, Japan Tuesday, January 7, 20 ...

a major challenge in central nervous system (CNS) drug development. This collaboration reflects renewed interest in nucleic acid-based therapies, particularly for CNS disorders, an area with both ...

The clinical nurse specialist in uro-oncology is undervalued and underdeveloped, according to a discussion paper on the role of this clinician.